相关实验视频
Updated: Feb 11, 2026

08:22
Studying Copper Nanoparticle-Induced Programmed Cell Death in Bacteria
Published on: May 16, 2025
587
编程细胞死亡抑制剂:癌症治疗的新希望?
Yuting Zhong1, Yuan Zhang2,3, Lei Cheng2,3
1Center for Clinical Pharmacy, Cancer Center, Department of Pharmacy, Zhejiang Provincial People's Hospital (Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, China.
World journal of surgical oncology
|February 10, 2026
概括
除了细胞亡之外,新的编程细胞死亡 (PCD) 途径可以通过帮助免疫逃避和转移来促进瘤的进展. 针对这些途径的抑制剂提供了新的抗癌治疗策略.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 免疫学 免疫学 免疫学
背景情况:
- 多种编程细胞死亡 (PCD) 途径,包括亡,烧亡,铁亡,自细胞死亡和亡,在瘤开始和进展中起着双重作用.
- 虽然最初通过瘤细胞消除研究了抗癌作用,但新出现的证据表明,这些PCD途径也可以促进瘤的进展.
研究的目的:
- 审查新型PCD模式在癌症中的双重作用.
- 探索这些细胞死亡途径如何在特定条件下促进瘤进展.
- 突出针对新型PCD途径的治疗潜力.
主要方法:
- 关于癌症中编程细胞死亡途径的最新科学文献的综述.
- 分析PCD模式影响瘤微环境 (TME) 的机制.
- 检查针对新型细胞死亡途径的新兴治疗策略.
主要成果:
- 新的PCD途径可以通过促进免疫逃避,转移传播和治疗耐药性来促进瘤的进展.
- 这些效应是由损伤相关分子模式 (DAMPs) 的释放介导的,导致炎症和免疫抑制.
- 特定的TME条件和遗传背景决定了PCD途径是抗瘤还是促瘤.
结论:
- 针对新型细胞死亡模式的抑制剂,如necrostatin-1, dimethyl fumarate和ferrostatin-1,在抗瘤疗法中显示出转化潜力.
- 了解PCD途径的复杂作用为改善患者预后提供了新的视角.
- 对PCD抑制剂的进一步研究可能会导致新的抗癌治疗策略.
相关概念视频
Cancer Therapies
10.2K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.2K
Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
Autophagic Cell Death
4.6K
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
4.6K
Overview of Cell Death
10.2K
Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
10.2K
Eukaryotic Transcription Inhibitors
11.0K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
11.0K
Gene Therapy
27.7K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.7K

